How were Hospira's earnings last quarter?

Hospira Inc (NYSE:HSP) posted its earnings results on Wednesday, July, 29th. The healthcare company reported $0.85 EPS for the quarter, beating analysts' consensus estimates of $0.78 by $0.07. The healthcare company had revenue of $1.20 billion for the quarter, compared to analysts' expectations of $1.18 billion. The company's revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.72 EPS.

What other stocks do shareholders of Hospira own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hospira investors own include Gilead Sciences (GILD) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Twitter (TWTR) , Allergan (AGN) , Bank of America (BAC) , Citigroup (C) , Costco Wholesale (COST) , Chevron (CVX) and Express Scripts (ESRX) .

NYSE:HSP

Hospira (HSP) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free HSP Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Hospira alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Hospira Stock (NYSE:HSP)

Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

HSP Stock News Headlines

April 17, 2024 | morningstar.com

Hanoi Synthetic Paint JSC HSP

October 6, 2023 | msn.com

Mental health coaching can help bridge the gap in provider shortage in Kansas

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 20, 2023 | theguardian.com

The ‘missing personality type’: could you be a Highly Sensitive Person?

March 21, 2023 | proactiveinvestors.com

HealthLynked awarded patent for "Secure Patient Access via Healthcare Service Provider Specific Wireless Access Point”

February 11, 2023 | yahoo.com

Those who invested in Hargreaves Services (LON:HSP) three years ago are up 65%

February 10, 2023 | thestreet.com

Hospira Stock Falls On Unusually High Volume (HSP)

January 17, 2023 | msn.com

Sikkim didn't get due share of development, bring HSP to power for real change: Bhaichung to people

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

January 9, 2023 | finanznachrichten.de

Go Metals Corp.: Go Metals Results from PGE Zone Nickel-Copper Sulphide

January 9, 2023 | ca.finance.yahoo.com

Go Metals Results from PGE Zone Nickel-Copper Sulphide

December 6, 2022 | finance.yahoo.com

Go Metals Initial Drill Results from PGE Central Zone

December 5, 2022 | juniorminingnetwork.com

Go Metals Announces Initial Drill Results from PGE Central Zone

October 25, 2022 | proactiveinvestors.com

Falcon Gold expands its HSP south project in southern Quebec by 70%

August 26, 2022 | finance.yahoo.com

Biotechnology Traded below Moving Averages in Last Week of August

June 21, 2022 | nz.finance.yahoo.com

Dalrada Financial Corporation Appoints Brian McGoff as President and Chief Operating Officer

May 3, 2022 | thestreet.com

5 Stocks Setting New 52-Week Highs

February 22, 2022 | thestreet.com

'Mad Money' Lightning Round: BorgWarner Is a Buy

January 14, 2022 | thestreet.com

Hospira (HSP) Stock Spikes Today on $17 Billion Pfizer Merger

October 26, 2021 | finance.yahoo.com

Dollar hits Pfizer; Merck 'blew away' estimates

August 19, 2021 | apnews.com

Conduent To Provide Advanced Claims Administration Solution to Help Eastpointe Health Deliver ...

See More Headlines

Receive HSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hospira and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 7/29/2015
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: N/A
Industry: N/A
Sub-Industry: Pharmaceuticals
Current Symbol: NYSE:HSP
CUSIP: 44106010
CIK: 1274057
Web: www.hospira.com
Phone: +1-847-9376472
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

HSP Stock Analysis - Frequently Asked Questions

How were Hospira's earnings last quarter?: Hospira Inc (NYSE:HSP) posted its earnings results on Wednesday, July, 29th. The healthcare company reported $0.85 EPS for the quarter, beating analysts' consensus estimates of $0.78 by $0.07. The healthcare company had revenue of $1.20 billion for the quarter, compared to analysts' expectations of $1.18 billion. The company's revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.72 EPS.
What other stocks do shareholders of Hospira own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Hospira investors own include Gilead Sciences (GILD), Johnson & Johnson (JNJ), Thermo Fisher Scientific (TMO), Twitter (TWTR), Allergan (AGN), Bank of America (BAC), Citigroup (C), Costco Wholesale (COST), Chevron (CVX) and Express Scripts (ESRX).

This page (NYSE:HSP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Hospira (HSP) Stock Price, News & Analysis

About Hospira Stock (NYSE:HSP)

HSP Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

HSP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info